270 related articles for article (PubMed ID: 24937378)
21. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
22. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
Ranpise NS; Korabu SS; Ghodake VN
Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement.
Tran TH; Ramasamy T; Truong DH; Choi HG; Yong CS; Kim JO
AAPS PharmSciTech; 2014 Dec; 15(6):1509-15. PubMed ID: 25035071
[TBL] [Abstract][Full Text] [Related]
24. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Tsai MJ; Wu PC; Huang YB; Chang JS; Lin CL; Tsai YH; Fang JY
Int J Pharm; 2012 Feb; 423(2):461-70. PubMed ID: 22193056
[TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers.
Shi F; Zhao Y; Firempong CK; Xu X
Pharm Biol; 2016 Oct; 54(10):2320-8. PubMed ID: 26986932
[TBL] [Abstract][Full Text] [Related]
26. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers.
Raval S; Jani P; Patil P; Thakkar P; Sawant K
Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598
[No Abstract] [Full Text] [Related]
28. Nanostructured lipid carriers for the topical delivery of tretinoin.
Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
[TBL] [Abstract][Full Text] [Related]
29. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
[TBL] [Abstract][Full Text] [Related]
30. Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.
Zhou J; Zhou D
Drug Des Devel Ther; 2015; 9():5269-75. PubMed ID: 26425076
[TBL] [Abstract][Full Text] [Related]
31. Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole.
Lin WJ; Duh YS
Eur J Pharm Biopharm; 2016 Nov; 108():297-303. PubMed ID: 27449633
[TBL] [Abstract][Full Text] [Related]
32. Insulin-loaded alginic acid nanoparticles for sublingual delivery.
Patil NH; Devarajan PV
Drug Deliv; 2016; 23(2):429-36. PubMed ID: 24901208
[TBL] [Abstract][Full Text] [Related]
33. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin.
Fathi HA; Allam A; Elsabahy M; Fetih G; El-Badry M
Colloids Surf B Biointerfaces; 2018 Feb; 162():236-245. PubMed ID: 29197789
[TBL] [Abstract][Full Text] [Related]
34. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
[TBL] [Abstract][Full Text] [Related]
35. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
You P; Yuan R; Chen C
Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
[TBL] [Abstract][Full Text] [Related]
36. Nano-transfersomes as a novel carrier for transdermal delivery.
Chaudhary H; Kohli K; Kumar V
Int J Pharm; 2013 Sep; 454(1):367-80. PubMed ID: 23871739
[TBL] [Abstract][Full Text] [Related]
37. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
Singh A; Neupane YR; Mangla B; Kohli K
J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
[TBL] [Abstract][Full Text] [Related]
38. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
Song J; Fan X; Shen Q
Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
[TBL] [Abstract][Full Text] [Related]
39. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
Wang Y; Wang S; Shi P
Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
